TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...
The decrease in death/HF with a single subcutaneous injection of the novel GP IIb/IIIa inhibitor seen at 30 days persisted.
Experts hope the findings will bring awareness to the idea that it’s not only heat that matters for adverse cardiovascular ...
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...
SAN DIEGO, CA—Among patients with atrial fibrillation (AF) undergoing left atrial appendage occlusion (LAAO) as part of the ANDES trial, overall 1-year results continue to give the edge to 2 months of ...
It’s “another piece to the puzzle” showing the strategy is safe and improves well-being in these patients, says Julia ...
Sticking to any seven out of eight dietary patterns was associated with better outcomes, data from the UK Biobank suggest.
This month features new weight-loss drugs in diabetes, a feature on AI’s creep into slide sets, a look ahead at TCT 2026, and ...
Egoavil and colleagues note that half of TAVI patients have anemia, in part because they tend to be older and frailer than ...
In addition to variation by type of cancer and treatment, general practitioners were more likely to prescribe than ...
Over the last decade, coronary interventions have gone up by 33% in France, primarily related to increases in elective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results